Improving decision-making for pulmonary arterial hypertension treatment
Official title: PHORA-Pulmonary Hypertension Outcome Risk Assessment
Funded at Icahn School of Medicine at Mount Sinai · NIH-10928758 · Data updated 2026-11-12
This study is creating a helpful tool called PHORA that will guide doctors in choosing the best treatments for people, both adults and kids, with pulmonary arterial hypertension (PAH), making it easier for them to get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | January 5, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $607,038 |
| NIH project number | 5R01HL164906-04 |
| Project ID | NIH-10928758 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include both adults and children diagnosed with pulmonary arterial hypertension.
✕Less likely to help
Patients with other forms of pulmonary hypertension that do not fall under the PAH category may not benefit from this research.
What this research studies
This research aims to develop a clinical decision support system called PHORA, which will assist healthcare providers in making informed treatment decisions for patients with pulmonary arterial hypertension (PAH). By analyzing data from various clinical trials and registries, the system will provide tailored recommendations for both adults and children. The project involves collaboration among experts in multiple fields, including biomedical engineering and computer science, to ensure the system is user-friendly and effective. Ultimately, the goal is to enhance patient outcomes and streamline clinical trial designs.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with pulmonary arterial hypertension.
How similar studies have gone: Previous research has shown promise in using clinical decision support systems to improve treatment outcomes in various medical fields, indicating potential success for this approach in PAH.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Benza, Raymond Louis — Icahn School of Medicine at Mount Sinai
- Study coordinator: Benza, Raymond Louis
Related research
Other NIH-funded projects on the same topics.
-
Understanding how CD4 T cells fuel schistosomiasis-related lung disease
A study explores how specific immune cells and inflammatory signals in schistosomiasis may contribute to pulmonary hypertension in people affected by the disease.
-
CD4 T Cells, Schistosoma, and Pulmonary Hypertension: Understanding How Immune Cells Drive Disease
A human-health focused study uses a mouse model and human samples to explore how immune cells and inflammation may contribute to a lung blood vessel disease linked to schistosomiasis.
-
CD4 T Cells and Schistosoma-Related Pulmonary Hypertension
A study to understand how specific immune cells behave in a lung complication caused by schistosomiasis, with the goal of finding targets to prevent or treat it.
-
Clinical CT Imaging to identify and subtype pulmonary hypertension in COPD
A new CT imaging approach aims to help doctors detect and classify pulmonary hypertension in people with COPD.
-
Right heart remodeling in pulmonary hypertension
In people with pulmonary hypertension, researchers are studying how the right side of the heart changes and why it fails, with the goal of finding new treatments.
-
TEMPO-PH: How the right heart adapts in pulmonary hypertension over time
A study to build a detailed molecular portrait of why the right side of the heart fails in pulmonary hypertension and how a common heart medicine might help.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.